Cancer Genetics enters strategic partnership with Genecast Biotechnology in China
Cancer Genetics announced it has signed an exclusive distribution agreement with Genecast Biotechnology to market, distribute and sell the Tissue of Origin® Test in China. TOO is a microarray-based gene expression test that analyzes a tumor’s genomic information to help identify its origin. October 18, 2018